Chiang Jason, Furler John, Boyle Douglas, Clark Malcolm, Manski-Nankervis Jo-Anne
Aust Fam Physician. 2017 Oct;46(10):764-768.
Cardiovascular disease (CVD) is a major cause of death in Australia. Electronic medical record (EMR)-based clinical decision support (CDS) tools have the potential to support absolute CVD risk (ACVDR) evaluation and management. The objective of this study was to test the acceptability and feasibility of the Treat to Target CVD (T3CVD), an EMR-based CDS tool, for the evaluation of ACVDR in general practice.
Five general practitioners (GPs) piloted the T3CVD tool in their clinic. Interviews with the clinicians explored the acceptability and feasibility of the T3CVD tool.
The T3CVD tool was acceptable and, in the small pilot, was shown to have the capacity to support GPs in ACVDR assessment and management, and to encourage patient participation and motivation. Technical and structural factors important to ensure feasibility of the tool were identified.
With further development, the T3CVD tool has the potential to improve ACVDR assessment and management in primary care.
心血管疾病(CVD)是澳大利亚主要的死亡原因。基于电子病历(EMR)的临床决策支持(CDS)工具具有支持绝对心血管疾病风险(ACVDR)评估和管理的潜力。本研究的目的是测试基于EMR的CDS工具——“治疗达靶心血管疾病(T3CVD)”在全科医疗中评估ACVDR的可接受性和可行性。
五名全科医生(GP)在其诊所试用了T3CVD工具。对临床医生的访谈探讨了T3CVD工具的可接受性和可行性。
T3CVD工具是可接受的,并且在小规模试用中显示有能力支持全科医生进行ACVDR评估和管理,并鼓励患者参与和积极性。确定了对确保该工具可行性很重要的技术和结构因素。
随着进一步发展,T3CVD工具有可能改善初级保健中的ACVDR评估和管理。